Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Unveiling Genomic Rearrangements in Engineered iPSC Lines by Optical Genome Mapping.
Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025
Unveiling genomic rearrangements in engineered iPSC lines by optical genome mapping.
Journal: Molecular therapy. Methods & clinical development
Published: May 09, 2025
CHMP2A regulates broad immune cell-mediated antitumor activity in an immunocompetent in vivo head and neck squamous cell carcinoma model.
Journal: Journal for immunotherapy of cancer
Published: April 11, 2024
iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting.
Journal: Frontiers in immunology
Published: December 21, 2021
Into the multiverse of gene edited NK cell-based therapeutic strategies.
Journal: Cell stem cell
Published: December 03, 2021
Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults.
Journal: Expert opinion on biological therapy
Published: September 29, 2020
Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles.
Journal: Frontiers in immunology
Published: May 12, 2020
Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition.
Journal: Nature medicine
Published: August 07, 2015
Global transcriptome and chromatin occupancy analysis reveal the short isoform of GATA1 is deficient for erythroid specification and gene expression.
Journal: Haematologica
Published: June 25, 2014
Last Updated: 09/26/2026